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Oxidative stress plays the central role in the pathogenesis and progression of diabetic complications. 
The present study aims to investigate the beneficial effect of oral administration of flavone baicalein 
in streptozotocin-nicotinamide (STZ-NA) induced diabetic rats by measuring oxidative stress markers, 
antioxidant enzyme activities and expression analysis of antioxidant genes. Experimental diabetes 
was induced by a single intraperitoneal (i.p.) injection of STZ (55 mg /kg b.wt), 15 min after the i.p. 
administration of NA. At the end of the experimental period, thiobarbituric acid reactive substances 
(TBARS), activities of antioxidant enzymes and expression levels of superoxide dismutase (SOD), 
catalase (CAT), glutathione (GSH) and glutathione peroxidase (GPx) were measured in diabetic rats 
along with serum biochemical parameters namely total cholesterol (TC), total triglyceride (TG), 
aspartate transaminase (AST) alanine transaminase (ALT) and glycosylated hemoglobin (HbA1c). Oral 
administration of baicalein (40 mg/kg b.wt/day) demonstrated a significant ameliorative effect on all 
studied biochemical and oxidative stress parameters. Biochemical findings were corroborated by qPCR 
expression analysis which showed significant upregulation of antioxidant genes in diabetic rats. These 
results suggest that baicalein supplementation may reduce diabetes and its complications by suppressing 
oxidative stress and enhancing gene expression and antioxidant enzyme activities in diabetic rats.
Keywords: Diabetes. Streptozotocin/pharmacology. Baicalein/pharmacology. Nicotinamide/
pharmacology. Glibenclamide. Diabetes Mellitus/ Experimental/prevention and control. Gene Expression/
drug effects. Antioxidants/pharmacology. Glyburide/pharmacology. Rats.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disorder 
characterized by elevated levels of glucose in the blood 
(hyperglycemia) and insufficiency of production or action 
of insulin produced by the pancreas in our body (Maritim, 
Sanders, 2003). Diabetes is currently affecting more than 
100 million people worldwide. Oxidative stress plays 
a pivotal role in the onset and progression of diabetic 
complications (Ayepola, Brooks, Oguntibeju, 2014). 
Oxidative stress results from an imbalance between 
the production and neutralization of reactive oxygen 
species (ROS) such as highly reactive hydroxyl radicals, 
superoxide anion, peroxyl radicals, singlet oxygen, 
peroxynitrite, and hydrogen peroxide (Sellamuthu et 
al., 2013). Oxidative stress-induced complications from 
diabetes include neuropathy, coronary artery disease, 
nephropathy, retinopathy (Phillips et al., 2004). There 
are several reports on altered antioxidant defenses and 
the role of free radicals in the etiology of diabetes and 
its complications (Raza et al., 2011). While the external 
supply of insulin and other medications can control many 
aspects of diabetes, numerous complications that affect the 
kidney, peripheral nerves, vascular system, retina, lens, 
and skin are common and are extremely important factors 
in terms of longevity and quality of life (Maritim, Sanders, 
2003). Increased oxidative stress is a key participant in 
the development and progression of diabetes and different 
diabetes-related complications (Giacco, Brownlee, 2010). 
It is very important to explore the relationship between 
free radicals, diabetes, and its complications, and to reveal 
the mechanisms by which increased oxidative stress 
accelerates the development of diabetic complications, in 
an effort to find effective treatment options. 
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Neutralization of oxidants by increased antioxidant 
availability may mitigate the effects associated with 
oxidative stress in DM. The antioxidant systems that 
fight free radical-mediated damage involves enzymes 
such as superoxide dismutase (SOD), catalase (CAT), 
glutathione (GSH), glutathione peroxidase (GPx) as 
well as non-enzymatic substances such as vitamins A, 
C and E, glutathione, α-lipoic acid, carotenoids, trace 
elements like copper, zinc and selenium, as well as 
coenzyme Q10 (Dehghan, Gargari, Asgharijafarabadi, 
2013). As a traditional medicine, plants represent a 
valuable alternative to control and treat diabetes mellitus 
with minimal or no side effects in clinical settings, plants 
also entail relatively lower costs than oral synthetic 
hypoglycemic agents (Gupta et al., 2005). According 
to ethnobotanical reports, approximately 800 plants 
exhibit antidiabetic properties (Patel et al., 2012), and 
many plants have been recommended for treatment 
of diabetes (Yajnik, 2001). The principal chemical 
compounds isolated and identified from these plants are 
glycans, proteins, and mucilages. Other compounds, 
such as phenolics, flavonoids, steroids, triterpenoids, 
and alkaloids, with hypoglycemic activity, have been 
extracted from these traditionally used medicinal 
plants by using different organic solvents (Gupta et al., 
2006).
One such flavonoid found in the plant Scutellaria 
baicalensis Georgi is baicalein which shows antioxidant 
(Gao et al., 1999), anti-inflammatory (Chi et al., 2003), 
and anti-cardiovascular effects (Wang, Mehendale, 
Yuan, 2007). S. baicalensis is a medicinal plant which 
is cultivated in Siberia, Mongolia, the Russian Far East, 
China, and Korea. The root of S. baicalensis, also known 
as Huangqin in Chinese, has been used as an ingredient in 
traditional Chinese medicine formulations for thousands of 
years. There are more than 40 flavonoids identified from 
Huangqin that are primarily conjugated with a glucose 
molecule to form glycosides. Baicalein, baicalin, wogonin, 
and wogonoside are the main bioactive components 
found in Huangqin (Li-Weber, 2009). Studies on whether 
baicalein has an anti-diabetic effect are scarce. But the 
evidence suggests that baicalein have effects on diabetes-
related complications. Previous studies of Fu et al. (2014) 
indicated that baicalein reduces blood glucose levels, 
improves circulating insulin concentration and preserves 
islet β-cell mass in obese diabetes mice, suggesting that 
this compound may have an anti-diabetic effect as loss of 
β-cell mass and function is central to the development of 
diabetes. 
Streptozotocin-nicotinamide (STZ-NA) has been 
extensively used to induce diabetes in experimental 
animals (Aboonabi, Rahmat, Othman, 2014). STZ causes 
pancreatic B-cell damage, while NA is administered 
to partially protect insulin-secreting cells against STZ 
(Szkudelski, 2012). The cytotoxic action of STZ is 
associated with the production of ROS which causes 
oxidative stress and oxidative damage in the cells (Lenzen, 
2008). Lipid peroxidation is the main marker for oxidative 
stress determination. Increased oxidative stress denoted 
by indices of increased lipid peroxidation, depletion of 
endogenous antioxidant enzyme activities in plasma etc. 
is commonly observed in the STZ-NA induced diabetic 
rats (Nizamutdinova et al., 2009). 
Glibenclamide (GC) is a Sulfonylurea anti-diabetic 
drug used in the treatment of diabetes mellitus. Several 
antioxidant studies suggest that GC (Elmali, Altan, Bukan, 
2004) has the potential to counteract the ROS-mediated 
oxidative stress.
The present study was undertaken to evaluate the 
potential effect of baicalein to protect the antioxidant status 
and ameliorate oxidative stress in STZ-NA diabetic rats. 
Additionally, the effects of baicalein on the expression 
levels of antioxidant genes in liver tissues of STZ-NA 
induced diabetic rats using qPCR system were studied and 
compared to glibenclamide, a hypoglycemic drug used for 
type 2 diabetes treatment. As diabetes is a growing public 
health problem, it is very important to search for novel, 
low side effects and affordable compounds which can 
attenuate induced oxidative stress and provide effective 
treatment for this disease. The present work aims towards 
this goal.
MATERIALS AND METHODS
Animals
Thirty adult male albino Wistar rats weight (180 
- 200 g) were purchased from College of Veterinary 
Sciences, Khanapara, Assam, India. The animals were 
housed in standard polypropylene cages with 12 h dark/
light cycles and were maintained at 25±2 °C. Animals 
were allowed to acclimatize for one week, prior to the 
experimental procedure. An ethical clarence approval 
for animal use and the experimental protocol was 
obtained from Gauhati University Institutional Ethical 
committee (Animal ethics approval number: IAEC/
PER/2016/2017-2 dated 30/01/2017). The rats were fed a 
commercial standard pellet diet (Lab 030525, Hindustan 
Animal Feeds, Gujrat, India), with the chemical 
composition of protein 24.6 %, fat (Ether extract) 4.8 %, 
fat (Acid hydrolysis) 5.5 %, crude fiber 4.1 %, nitrogen-
free extract 50.1%.
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Chemicals and drugs
Baicalein, Glibenclamide, Nicotinamide, and 
Streptozotocin were purchased from Sigma-Aldrich 
Chemicals (St. Louis, MO, USA) and were stored at 
2 - 4 °C for further use. All the other chemicals were 
of analytical grade and were purchased from standard 
commercial suppliers.
Experimental design
All the experimental rats were divided into six 
groups, each comprising of five rats designated as follows:
Group 1 (NC): Normal control rats receiving 0.1 M citrate 
buffer (pH 4.5). 
Group 2 (NC+BC): Normal control rats treated with 
baicalein (40 mg/kg b.wt/day) for 30 days.
Group 3 (NC+GC): Normal control rats treated with 
glibenclamide (0.6 mg/kg b.wt/day) for 30 days.
Group 4 (DC): Diabetic control treated with STZ+NA (55 
and 120 mg/kg b.wt/day respectively).
Group 5 (DC+BC): Diabetic rats treated with baicalein 
(40 mg/kg b.wt/day) for 30 days.
Group 6 (DC+GC): Diabetic rats treated with glibenclamide 
(0.6 mg/kg b.wt/day) for 30 days.
 At the end of the total experimental period, the 
animals were fasted overnight, recorded the final body 
weight and sacrificed, by cervical dislocation. The serum 
samples of each rat were obtained by centrifuging blood 
samples at 4000 x g at 25 °C for 4 min and stored at -20 °C 
for further biochemical parameters analysis.
Induction of diabetes
Overnight fasted rats were injected with a single 
intraperitoneal (i.p.) injection of freshly prepared 
STZ (55mg/kg b.wt.) in 0.1 M cold citrate buffer 
(pH 4.5), and control rats were injected with citrate 
buffer alone. Nicotinamide was dissolved in normal 
saline and administered (120 mg/kg b.wt.) 15 min before 
STZ administration (Masiello et al., 1998). The rats 
were allowed to drink 5% glucose solution overnight 
to overcome the drug-induced hypoglycemia. The 
development of diabetes was confirmed by the elevated 
glucose levels in the blood, which was determined at 72 h 
by means of a glucometer (Roche Diabetes Care India Pvt. 
Ltd. Mumbai, India). The rats with fasting blood glucose 
level higher than 180 mg/dl were considered to be diabetic 
and used in the experiment. The treatment was started on 
the 4th day after STZ injection, considering that as the 1st 
day of treatment, which was continued for 30 days.
Preparation of baicalein
Baicalein (40 mg/kg b.wt/day) was dissolved in 
dimethyl sulfoxide (DMSO) before it was administered.
Preparation of glibenclamide
Glibenclamide (0.6 mg/kg b.wt/day) was dissolved 
in dimethyl sulfoxide (DMSO) before it was administered.
Preparation of tissue homogenate for biochemical 
parameters
For tissue preparation, the animals were fasted 
overnight, anesthetized and sacrificed by cervical 
dislocation. The liver tissues from all the rats were 
excised and rinsed with ice-cold saline. The preparation 
of tissue homogenates was done homogenizing a known 
amount of the liver in 0.1 M Tris-HCl buffer, pH 7.4 at 
4 °C, employing a mortar and a pestle. The homogenates 
were centrifuged at 3000 x g for 10 min at 4 °C using 
a centrifuge. The supernatant was collected as tissue 
homogenate, and the same was used for the assay of 
oxidative stress markers.
Biochemical analysis
The biochemical parameters for total cholesterol 
(TC), total triglyceride (TG), aspartate transaminase 
(AST) and alanine transaminase (ALT) was done by using 
commercial kits (Span Diagnostics Ltd., India).
Estimation of thiobarbituric acids content
Tissue homogenates were used for the oxidative 
stress marker estimations. The thiobarbituric acids 
content was assayed by measuring thiobarbituric acid 
reacting substances (TBARS) according to Ohkawa, 
Ohishi, Yagi (1979). Briefly, to 0.2 mL of tissue 
homogenate, 0.2 mL of SDS (8.1 %), 1.5 mL of acetic 
acid (20 %, pH above 3), and 1.5 mL of TBA (0.8 % 
aq sol) were added. The mixture was taken to a final 
volume of 4 mL with water and then heated in a water 
bath at 95 °C for 60 min. After cooling with tap water, 1 
m L of water and 5 mL of n butanol/pyridine (15:1 v/v) 
mixture were added and shaken vigorously. After that it 
was centrifuged at 4000 x g for 10 min; then, the organic 
layer was taken and measured at 532 nm absorbance. The 
1,1´,3,3´-tetramethoxypropane was used as a standard. 
The level of lipid peroxides was expressed as moles of 
TBARS / 100 g of tissue.
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Determination of superoxide dismutase (SOD) 
activity
Superoxide dismutase was assayed following the 
method of Misra, Fridovich (1972). The tissue homogenate 
(0.1 mL) was mixed by reaction mixtures that contained 
sodium carbonate (1 mL, 50 mM), nitroblue tetrazolium 
(0.4 mL, 25 𝜇m), and hydroxylamine hydrochloride 
(0.2 mL, 0.1 mM). The absorbance of the samples was 
measured at 560 nm.
Determination of catalase (CAT) activity
The activity of catalase was assayed according to the 
method of Takahara et al. (1960). Phosphate buffer (1.2 
mL) and 0.2 mL of tissue homogenate were mixed, and 
the reaction was started by the addition of 1.0 mL of H2O2 
solution. The decrease in the absorbance is measured at 
240 nm at 30 s intervals for 3 min.
Determination of reduced glutathione (GSH) 
activity
Reduced glutathione was determined by the method 
of Sedlak, Lindsay (1968). 0.5 mL of tissue homogenate 
was mixed with 1.5 mL of 0.2 M Tris buffer with pH 8.2 
and then contents were mixed with 0.1 mL of 0.01 M 
Ellman’s reagent, (5,5’dithiobis-2-nitro-benzoic acid or 
DTNB), then centrifuged at 3000 x g for 15 min at RT. 
The absorbance was read at 412 nm. The GSH content 
was calculated as mole GSH conjugate formed/gram tissue 
using molar extinction coefficient of 13.6×103 M−1 cm−1.
Determination of glutathione peroxidase (GPx) 
activity
The activity of glutathione peroxidase was assayed by 
the method of Rotruck et al. (1973). The reaction mixture 
containing 0.2 mL of EDTA, 0.1 mL of sodium azide, 0.1 mL 
of H2O2, 0.2 mL of reduced glutathione, 0.4 mL of phosphate 
buffer and 0.2 mL tissue homogenate was incubated at 37 
°C for 10 min. The reaction was arrested by the addition of 
3 mL of disodium hydrogen phosphate and 1.0 mL DTNB 
was added to the supernatant, and the colour developed 
was read at 420 nm immediately. The enzyme activity 
was calculated using the molar extinction coefficient.
Extraction of RNA and cDNA Conversion from 
liver tissue for qPCR analysis
To study the expression pattern of oxidative stress 
genes, approximately 300 mg of each rat liver tissue 
was cleaned with saline. Total RNA was isolated using 
TRIzol reagent according to the manufacturer’s protocol 
(Life Technologies, Carlsbad, USA). RNA purity and 
concentration were measured by the NanoDrop quantifier 
(ThermoFisher Scientific, Waltham, Massachusetts, 
USA). For cDNA conversion, two micrograms of total 
RNA was reversed transcribed in a total reaction volume 
of 20 μL by using Superscript III Reverse Transcriptase 
(Invitrogen, Life Technology, Carlsbad, USA) enzyme 
following manufacturer’s protocols. cDNA produced was 
further amplified by the qPCR system using the designed 
set of primers listed in Table I. qPCR was performed with 
Rotor-Gene Q (Qiagen, Hilden, Germany) PCR System 
using SYBR PremixEx Taq II master mix according to the 
protocols provided by the manufacturer (TAKARA BIO 
INC. Shiga, Japan). Briefly, PCR was performed in a final 
volume of 20 μL including 2 μl of 100 ng sample cDNA, 
0.2 μL of 100 nM forward and reverse primers, and 10 
μL Power SYBR green PCR Master Mix. The following 
thermal cycling profile was used (40 cycles): 94 °C for 
20 s, and 56 °C for 20 s, 72 °C for 20 s. Standard curves 
for each gene were generated by 1:5 dilutions of cDNA 
to determine the PCR efficiency of target and reference 
gene. Standard curves were established by plotting the 
threshold cycle Ct vs. Log10 (cDNA). The slope (S) 
obtained from the standard curve was used to calculate 
PCR efficiency by the following equation: PCR efficiency 
(E) = (10 –1/slope –1) × 100. Using the Ct comparative 
method, the relative abundance of the target transcript 
was calculated from triplicate samples after normalization 
TABLE I - Primers used in qPCR
Gene Primer (5’-3’)
SOD Forward GTCCACGAGAAACAAGATGA 
Reverse ATCCCAATCACACCACAAG 
CAT Forward GAATGAGGAGGAGAGGAAAC 
Reverse GGTGGACGTCAGTGAAAT 
GSH Forward CCCAATGGAGTAACAAGTAGG 
Reverse GAGCAGGAAGGAGAGAGAA 
GPx Forward GGGACTACACCGAAATGAA 
Reverse CCTGATGTCCGAACTGATT 
GAPDH Forward TGCACCACCAACTGCTTAGC 
Reverse GGATGCAGGGATGATGTTCT 
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against a housekeeping gene. The housekeeping gene 
GAPDH was chosen in this study specifically as the 
most stably expressed reference gene for normalization 
to ensure reliable results and highest accuracy of 
the analysis. The mRNA levels (arbitrary units) are 
expressed in relation to those of the control rats. Relative 
quantification was calculated using the 2-ΔΔCt method, where 
ΔΔCt = (Ct, target − Ct, GAPDH) treated sample − 
(Ct, target − Ct, GAPDH) control sample. qPCR results are 
presented as the mean and SD of the relative fold changes 
to 2-ΔΔCt (Livak, Schmittgen, 2001).
Statistical analysis
All data are expressed as means and standard 
deviation. Statistical analysis was performed with one-
way analysis of variance (ANOVA), followed by Tukey’s 
Multiple Comparison Test using GraphPad Prism Software 
and P < 0.05 was considered as significant. **P < 0.05; 
***P < 0.01 when compared with control group and ##P 
< 0.05; ###P < 0.01 when compared with diabetic group.
RESULTS
Effect of the baicalein treatment on blood glucose 
level, body weight, HbA1c and TBARS level
Measurement of blood glucose levels and body 
weight are important factors in the diabetic study 
(Pournaghi et al., 2012). Diabetic rats showed a significant 
(P < 0.05) increase in blood glucose levels and significant 
(P < 0.05) decrease in body weight when compared 
to normal control rats. Administration of baicalein 
(40 mg/kg b.wt.day) in diabetic rats significantly (P < 0.05) 
lowered the blood glucose level (Figure 1A) and increased 
body weight (Figure 1B) when compared to untreated 
diabetic rats. Similarly, HbA1c level in diabetic rats 
receiving baicalein treatment was significantly (P < 0.05) 
lower than for untreated diabetic rats (Figure 1C). The 
level of TBARS has been demonstrated to be a reliable 
marker for oxidative stress (Al-Dosari et al., 2017). There 
was a significant (P < 0.05) increase in TBARS in the liver 
of diabetic rats compared to normal control rats. Baicalein 
FIGURE 1 (A-D) - Effect of baicalein supplementation on blood glucose, body weight, % HbA1C and TBARS levels of rats in 
different experimental groups. Data were expressed as mean ± SD and analyzed using one-way ANOVA followed by Tukey’s 
Multiple Comparison Tests. Values are statistically significant at P < 0.05; **P < 0.05; ***P < 0.01 when compared with control 
group and ##P < 0.05; ###P < 0.01 when compared with diabetic group. NC: normal control, NC+BC: normal control treated with 
baicalein, NC+GC: normal control treated with glibenclamide, DC: diabetic control, DC+BC: diabetic rats treated with baicalein, 
DC+GC: diabetic rats treated with glibenclamide.
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treatment significantly (P < 0.05) inhibited the formation 
of TBARS in liver tissue and reduced TBARS level in 
the treatment group when compared to diabetic control 
rats (Figure 1D). Statistical differences (P < 0.05) were 
also found in (DC+BC) and (DC+GC) rats as compared 
to normal control rats in all the above studied parameters.
Effect of the treatment on biochemical 
parameters
The aspartate transaminase (AST) and alanine 
transaminase (ALT) activities were measured for the 
detection of possible liver damage. Activities of serum 
AST, ALT in the control and experimental groups are 
illustrated in Figure 2A and Figure 2B. There was a 
significant (P < 0.05) increase in the activities of AST, 
ALT in the serum of diabetic rats when compared to 
normal control rats. Treatment with baicalein to diabetic 
rats significantly (P < 0.05) decreased the enzymatic 
activities of AST and ALT. Significant (P < 0.05) reduction 
in triglyceride levels was observed in the treatment group 
compared to the diabetic control group (Figure 2C), which 
indicates that baicalein possesses a hypotriglyceridemic 
effect. A similar trend was observed in total cholesterol 
levels (Figure 2D). Reduction of circulating triglyceride 
and total cholesterol is an important aspect of the treatment 
of diabetes (Bitzur et al., 2009).
Effect of the treatment on activities of 
antioxidant enzymes and gene expression
The activities of enzymatic antioxidants such as 
superoxide dismutase (SOD), catalase (CAT), glutathione 
(GSH) and glutathione peroxidase (GPx) in the liver 
tissues of control and treatment group of rats are depicted 
in Figure 3(A-D). A significant (P < 0.05) reduction in the 
activities of SOD, CAT, GSH and GPx in the liver of STZ-
NA administered rats was observed. However, treatment 
with baicalein and glibenclamide increased the level of 
enzymatic antioxidant in the liver of diabetic rats, this 
increase was more significant (P < 0.01) in baicalein than 
glibenclamide (P < 0.05) treatment groups. qPCR results 
showed that gene expression levels of main antioxidant 
enzymes SOD, CAT, GSH, and GPx were suppressed 
FIGURE 2 (A-D) - Effect of baicalein supplementation on AST, ALT, Triglycerides and Total cholesterol in different experimental 
groups. Data were expressed as mean ± SD and analyzed using one-way ANOVA followed by Tukey’s Multiple Comparisons 
Tests. Values are statistically significant at P < 0.05; **P < 0.05; ***P < 0.01 when compared with control group and ##P < 0.05; 
###P < 0.01 when compared with diabetic group. NC: normal control, NC+BC: normal control treated with baicalein, NC+GC: 
normal control treated with glibenclamide, DC: diabetic control, DC+BC: diabetic rats treated with baicalein, DC+GC: diabetic 
rats treated with glibenclamide.
Modulatory effect of baicalein on gene expression and activity of antioxidant enzymes
Braz. J. Pharm. Sci. 2019;55:e18201 Page 7 / 11
in diabetic rats (Figure 3E). Treatment with baicalein 
significantly (P < 0.05) increased the expression of 
antioxidant genes in diabetic rat liver tissues. Expression 
levels were seen to be greater in baicalein treated rats than 
glibenclamide treated rats.
DISCUSSIONS
Diabetes mellitus is a severe health problem 
worldwide. An aging population, increased urbanization 
and more sedentary lifestyles have been linked to increase 
in the prevalence of diabetes (King, Aubert, Herman, 
1998). The absence of a perfect cure for diabetes as well 
as the potential side effects of most of the antidiabetic 
medications has led many researchers to identify natural 
substances that show potent hypoglycemic activity with 
fewer side effects (Saxena, Vikram, 2004). As oxidative 
stress plays the central role in the pathogenesis and 
progression of diabetic complications, therefore, it is 
believed that antioxidant compounds would prevent and/or 
delay the progression of diabetic complications (Brownlee, 
2001). The present study was conducted to assess the 
effects of baicalein on diabetes-induced oxidative stress 
by evaluating antioxidant enzyme activities and expression 
of antioxidant genes in the STZ-NA induced diabetic rats. 
Administration of STZ partially damages pancreatic cells 
(Szkudelski, 2012). The induction of diabetes with STZ in 
rat models caused a significant increase in blood glucose 
level, showing type II-like features as compared to the 
control group of rats, thus developing a state of oxidative 
stress. Baicalein, a flavonoid obtained from the roots of 
medicinal herb Scutellaria baicalensis Georgi, has been 
reported to have beneficial effects in diabetes-associated 
health complications (Ndisang, 2010). However, Fox et al. 
FIGURE 3 (A-E) - Effect of baicalein supplementation on activities of antioxidant enzymes and gene expression in different 
experimental groups. Data were expressed as mean ± SD and analyzed using one-way ANOVA followed by Tukey’s Multiple 
Comparisons Tests. Values are statistically significant at P < 0.05; **P < 0.05; ***P < 0.01 when compared with control group and 
##P < 0.05; ###P < 0.01 when compared with diabetic group. NC: normal control, NC+BC: normal control treated with baicalein, 
NC+GC: normal control treated with glibenclamide, DC: diabetic control, DC+BC: diabetic rats treated with baicalein, DC+GC: 
diabetic rats treated with glibenclamide.
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(2012) have demonstrated baicalein as an inducer of DNA 
damage and cell death by high-throughput genotoxicity 
assay in human ATAD5 cells. They showed that despite 
having genotoxic effects, baicalein did not cause any 
mutagenesis, further they observed that baicalein rapidly 
killed dividing cancer cells without causing potentially 
detrimental genomic instabilities and proved to be a 
chemotherapeutic agents. Recently, much interest has 
been focused on the antidiabetic effects of baicalein. 
In particular, it has been demonstrated that baicalein 
improves hyperglycemia and glucose intolerance, 
and promotes insulin secretion by inhibiting islet cell 
apoptosis in streptozotocin-induced diabetic mice (Fu et 
al., 2014). Baicalin, the glucuronide form of baicalein, 
also exerts beneficial effects on diabetes mellitus and its 
complications according to recent studies (Pu et al., 2012).
Lipid peroxide-mediated damage has been observed 
in the development of type 1 and type 2 diabetes. TBARS 
is the most commonly used indicator of lipid peroxidation 
(Lyons, 1991). In the present study, levels of TBARS 
were significantly elevated in liver, indicating increased 
oxidative stress and such results have also been represented 
by Jin et al. (2008) who reported elevated levels of TBARS 
in STZ-induced diabetic rats. Administration of baicalein 
significantly lowered the TBARS levels in diabetic treated 
groups compared with the untreated diabetic group, 
indicating inhibition of diabetes-induced oxidative stress. 
The present findings were in agreement with Sellamuthu 
et al. (2013) who reported reduced levels of TBARS upon 
oral administration of mangiferin and glibenclamide in 
diabetic rats in the liver and kidney tissues.
In general, increased blood glucose levels and 
severe loss of body weight characterize STZ-induced 
diabetes. The results of the present study are consistent 
with the observations of Gandhi, Sasikumar (2012). The 
spectrum of biochemical changes that typically occur in 
DM resembles those of liver diseases, from the secretion 
of abnormal liver enzymes to the end-stage liver failure 
(Moscatiello, Manini, Marchesini, 2007). The initial and 
most important indicators in assessing liver injury are 
levels of AST and ALT in in vivo (Hwang et al., 2005). 
Baicalein reduced the plasma triglycerides and total 
cholesterol contents which is an important aspect of the 
treatment of diabetes. AST and ALT levels are also showed 
improvement in the baicalein treated group as compared 
to diabetic control group. In diabetes, renal and hepatic 
failures are known to be the long-term consequences, 
therefore possible effects of the treatment with antioxidant 
on the hepatic tissue can be demonstrated by comparing 
the plasma levels of AST and ALT activities (Nathan, 
2014). In our study, the AST and ALT levels of the 
baicalein treated group of rats were found to be within 
the normal range.
Diabetes-induced oxidative stress results in alteration 
of both enzymatic and non-enzymatic antioxidant systems. 
The liver is equipped with potent antioxidants systems 
such as SOD, CAT, and GSH enzyme family, including 
GST and GPx, not only to neutralize free radicals but 
also to protect the liver cells from oxidative damage 
(Parveen et al., 2010). Hence, we assessed the activity 
of the most important antioxidant enzymes such as SOD, 
CAT, GSH, and GPx in liver tissue of diabetic rats upon 
baicalein treatment. The relative changes in activity in 
diabetic tissues compared with control tissues indicate 
an altered antioxidant system. In this context, treatment 
with baicalein appears to have resulted in a considerable 
reversal of antioxidant enzymes that were altered in 
diabetic tissues. In the present study, treatment with 
baicalein increased the activity of antioxidant enzymes 
as compared to diabetic rats. 
Previous research has proven that a decrease in 
SOD and CAT activities within a hyperglycaemic state 
leads to an increase in ROS, which eventually contributes 
to oxidation-induced liver damage (Han et al., 2006). 
The enzymatic activities of SOD, CAT, GSH, and GPx 
are significantly decreased in diabetes due to increased 
oxidative stress. In addition, to measure the activities of 
these enzymes, quantitative polymerase chain reaction 
(qPCR) was also used to study the expression levels of the 
antioxidant genes. In the present study, we found that the 
expression of these genes was decreased in the diabetic 
control group of rats as compared to the control group of 
rats. Induction of diabetes using STZ-NA was found to 
alter the expression of SOD, CAT, GSH, and GPx. The 
relative fold change of all the genes was observed to be 
significantly downregulated in diabetic control group and 
treatment with baicalein significantly upregulated the 
expression of all the tested genes. The present finding was 
in agreement with a recent study reporting that resveratrol 
administered to STZ-diabetic rats increased the gene 
expression of the antioxidant enzymes (Sadi, Baloglu, 
Pektas, 2015). 
The importance of maintaining the redox balance 
and reducing the blood glucose levels plays important 
role in combating diabetic micro and macrovascular 
complications (Rask-Madsen, King, 2013). The present 
study showed that baicalein has the ability to ameliorate 
oxidative stress in liver of STZ-NA induced diabetic 
rats which were ascertained by improved glycemic 
and reduced lipid peroxidation along with improved 
antioxidant enzymatic activities. Moreover, it increased 
the expression pattern of the antioxidant genes in liver of 
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STZ-NA induced diabetic rats. Antioxidant therapy is a 
potential future therapeutic strategy; increasing antioxidant 
levels in patients with DM-induced oxidative damage that 
may hopefully counter the effects of oxidative stress and 
inflammation, thereby reducing the severity of diabetic 
complications. The intervention for oxidative stress 
reduction is necessary for the overall therapy of diabetes 
which highlights the importance of antioxidants such as 
baicalein in the treatment of diabetes. Furthermore, the 
present study may contribute for future studies to establish 
pharmacological targets for novel therapies to prevent, 
reverse, or delay the onset of diabetic complications.
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